MHRA Approves New SCM Pharma Commercial Facility

News   Jun 20, 2013

 
MHRA Approves New SCM Pharma Commercial Facility
 
 
 

RELATED ARTICLES

SYGNIS AG Signs Supply Agreement with US Biological for the Lightning-Link Antibody Labelling Technology

News

SYGNIS AG, the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, announced it has signed a supply agreement with US Biological, Salem, MA, USA, for its Innova Lightning-Link® technology.

READ MORE

Novel Artificial Photosynthesis Device for Greener Ethylene Production

News

A team of scientists from the National University of Singapore (NUS) has developed a prototype device that mimics natural photosynthesis to produce ethylene gas using only sunlight, water and carbon dioxide.

READ MORE

Chemists Design More Efficient Microreactor Using 3D Printing

News

Researchers developed an electrochemical microreactor using additive manufacturing technology (commonly known as 3D printing). The newly developed microreactor was tested on synthesis of isoindolinones, which are found in many natural products, pharmaceuticals, and biologically active molecules.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE